Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Combined Modality Therapy  [Clear All Filters]
A
Abu-Raddad, LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Dye C, Halloran ME.  2009.  Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.. Proceedings of the National Academy of Sciences of the United States of America. 106(33):13980-5. Abstract
Antoni, MH, Lechner S, Diaz A, Vargas S, Holley H, Phillips K, McGregor BA, Carver CS, Blomberg B.  2009.  Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer.. Brain, behavior, and immunity. 23(5):580-91. Abstract
Appelbaum, FR.  2008.  Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(18):2927-9.
Armistead, PM, DeLima M, Pierce S, Qiao W, Wang X, Thall PF, Giralt S, Ravandi F, Kantarjian H, Champlin R et al..  2009.  Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(11):1431-8. Abstract
B
Bartenstein, M, Deeg HJ.  2010.  Hematopoietic stem cell transplantation for MDS.. Hematology/oncology clinics of North America. 24(2):407-22. Abstract
Bensinger, WI.  2009.  Role of autologous and allogeneic stem cell transplantation in myeloma.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 23(3):442-8. Abstract
Blumenthal, DT, Rankin C, Eyre HJ, Livingston RB, Spence AM, Stelzer KJ, Rushing EJ, Berger MS, Rivkin SE, Cohn AL et al..  2008.  External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.. Cancer. 113(3):559-65. Abstract
C
Chamberlain, MC.  2011.  Radiographic patterns of relapse in glioblastoma.. Journal of neuro-oncology. 101(2):319-23. Abstract
Chamberlain, MC.  2011.  How fine a slice: treatment of newly diagnosed glioblastoma with an epidermal growth factor receptor variant III peptide vaccine.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(17):e517-8;authorreplye519-20.
Chamberlain, MC, Glantz M.  2008.  Myelomatous meningitis.. Cancer. 112(7):1562-7. Abstract
Cheever, MA.  2008.  Twelve immunotherapy drugs that could cure cancers.. Immunological reviews. 222:357-68. Abstract
D
Dietz, AC, Orchard PJ, Baker KS, Giller RH, Savage SA, Alter BP, Tolar J.  2011.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.. Bone marrow transplantation. 46(1):98-104. Abstract
Disis, ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
Dugan, MJ, Maziarz RT, Bensinger WI, Nademanee A, Liesveld J, Badel K, Dehner C, Gibney C, Bridger G, Calandra G.  2010.  Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.. Bone marrow transplantation. 45(1):39-47. Abstract
E
Ettinger, DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA et al..  2008.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):228-69.
F
Fuchita, M, Ardiani A, Zhao L, Serve K, Stoddard BL, Black ME.  2009.  Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.. Cancer research. 69(11):4791-9. Abstract
G
Georges, GE, Maris MB, Maloney DG, Sandmaier BM, Sorror ML, Shizuru JA, Lange T, Agura ED, Bruno B, McSweeney PA et al..  2007.  Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(4):423-32. Abstract
Gopal, AK, Press OW, Shustov AR, Petersdorf SH, Gooley TA, Daniels JT, Garrison MA, Gjerset GF, Lonergan M, Murphy AE et al..  2010.  Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.. Leukemia & lymphoma. 51(8):1523-9. Abstract
Gralow, JR, Zujewski JA, Winer E.  2008.  Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(5):696-7.
H
Higano, CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford DE.  2008.  Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.. Cancer. 112(10):2181-7. Abstract
K
Kelly, K, Chansky K, Gaspar LE, Albain KS, Jett J, Ung YC, Lau DHM, Crowley J, Gandara DR.  2008.  Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(15):2450-6. Abstract
Kreuser, ED, Felsenberg D, Behles C, Seibt-Jung H, Mielcarek M, Diehl V, Dahmen E, Thiel E.  1992.  Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 3 Suppl 4:105-10. Abstract
Kumar, S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger WI, Comenzo RL, Lentzsch S, Munshi N, Niesvizky R et al..  2009.  Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.. Blood. 114(9):1729-35. Abstract
L
Lara, PN, Tangen CM, Conlon SJ, Flanigan RC, Crawford DE.  2009.  Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.. The Journal of urology. 181(2):512-6;discussion516-7. Abstract
Le, Q-TX, Moon J, Redman MW, Williamson SK, Lara PN, Goldberg Z, Gaspar LE, Crowley J, Moore DF, Gandara DR.  2009.  Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(18):3014-9. Abstract